Becton Dickinson (BDX) Cash & Equivalents (2009 - 2026)
Becton Dickinson's (BDX) quarterly Cash & Equivalents came in at $813.0 million in Q1 2026, up 21.89% year-on-year from $667.0 million in Q1 2025, and up 9.86% on a QoQ basis from $740.0 million in Q4 2025.
Becton Dickinson (BDX) Cash & Equivalents (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash & Equivalents data on file, last reported at $813.0 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents rose 21.89% year-over-year to $813.0 million in Q1 2026; TTM through Mar 2026 was $813.0 million, a 21.89% increase from a year earlier, with the FY2025 full-year figure at $567.0 million, down 66.98% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $813.0 million, up from $740.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for BDX reached as high as $4.5 billion in Q2 2024 and fell as low as $567.0 million in Q3 2025.
- Historically, Cash & Equivalents has averaged $1.5 billion across 5 years, with a median of $1.0 billion in 2022.
- Across the five-year window, Cash & Equivalents surged 383.1% in 2024 and sank 83.52% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $612.0 million in 2022, then soared by 92.81% to $1.2 billion in 2023, then plunged by 39.75% to $711.0 million in 2024, then gained by 4.08% to $740.0 million in 2025, then increased by 9.86% to $813.0 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $813.0 million in Q1 2026, $740.0 million in Q4 2025, and $567.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 2.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 813.00 Mn |
| Dec 31, 2025 | 740.00 Mn |
| Sep 30, 2025 | 567.00 Mn |
| Jun 30, 2025 | 735.00 Mn |
| Mar 31, 2025 | 667.00 Mn |
| Dec 31, 2024 | 711.00 Mn |
| Sep 30, 2024 | 1.72 Bn |
| Jun 30, 2024 | 4.46 Bn |
| Mar 31, 2024 | 2.35 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.42 Bn |
| Jun 30, 2023 | 923.00 Mn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 612.00 Mn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 2.56 Bn |
| Mar 31, 2022 | 3.15 Bn |
| Dec 31, 2021 | 1.90 Bn |
| Sep 30, 2021 | 2.28 Bn |
| Jun 30, 2021 | 3.15 Bn |